Discuss This Drug

Filgrastim

CHEBI:CHEBI_748824

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

generic_name
Filgrastim
rxcui
2595962
product_type
HUMAN PRESCRIPTION DRUG
listing_expiration_date
20251231
dosage_form
INJECTION, SOLUTION
route
INTRAVENOUS
marketing_category
BLA
marketing_start_date
19970519
package_marketing_start_date
19970519
active_ingredient_name
FILGRASTIM
active_ingredient_strength
300 ug/mL
unii
PVI5M0M1GW
nui
N0000175666
pharm_class_epc
Leukocyte Growth Factor [EPC]
pharm_class
Granulocyte-Macrophage Colony-Stimulating Factor [CS]
pharm_class_pe
Increased Myeloid Cell Production [PE]
pharm_class_cs
Granulocyte Colony-Stimulating Factor [CS]
labeler_name
Amneal Pharmaceuticals LLC
manufacturer_name
Amneal Pharmaceuticals LLC
brand_name
RELEUKO
brand_name_base
RELEUKO
product_ndc
70121-1568
application_number
BLA761082
spl_id
453cee35-313d-43db-ad1a-ce8fe5d3a56c
package_ndc
70121-1568-7
package_description
10 SYRINGE in 1 BOX (70121-1568-7) / .5 mL in 1 SYRINGE
spl_set_id
74e1ec6e-1630-4654-895c-2bd355f939e7
upc
0370121156970
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class